Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S3 pseudogene 1 (RPS3P1) is classified as a processed pseudogene in human genetics, meaning it resembles the ribosomal protein S3 gene but does not encode a functional protein[4][7]. Pseudogenes typically arise from duplication or retrotransposition events and lack regulatory elements or coding capacity needed for protein production. RPS3P1 is officially recognized by the HUGO Gene Nomenclature Committee and listed as a “pseudogene” rather than a protein-coding gene. It has no known molecular function, does not participate in any cellular processes, and is not a therapeutic or diagnostic target[4][7]. If you intended to refer to the functional RPS3 gene or ribosomal protein S3, please clarify, as RPS3 encodes a component of the 40S ribosomal subunit involved in protein synthesis and has roles in DNA repair and apoptosis[1][3][5], but RPS3P1 itself does not serve any recognized biological or therapeutic role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S3 pseudogene 1 (RPS3P1).